comparemela.com
Home
Live Updates
GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications : comparemela.com
GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); August 10, 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients
Related Keywords
Switzerland ,
France ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Massachusetts ,
United States ,
Paris ,
France General ,
Arunj Sanyal ,
Exchange Commission ,
Centers For Medicare Medicaid Services ,
Phepatology Communications ,
Euronext ,
Uncertainties Of The Company ,
Nasdaq ,
Medicaid Services ,
Non Invasive Test ,
Primary Biliary Cholangitis ,
Nasdaq Global Select Market ,
Private Securities Litigation Reform Act ,
Registration Document ,
Receiver Operating ,
comparemela.com © 2020. All Rights Reserved.